We have extensively characterized CDA1 to show that it plays a critical role in the development of fibrosis in rodent models of diabetic nephropathy and diabetes-associated vascular fibrosis [29,30,31,32,33]. Here, TSPYL2 is linked to diabetic kidney disease.